Your browser doesn't support javascript.
loading
Correction of thrombocytopenia caused by linezolid with scheduled sequential tedizolid use in patients with vertebral osteomyelitis by antibiotic resistant Gram-positive organisms.
Ueda, Takashi; Nakajima, Kazuhiko; Ichiki, Kaoru; Ishikawa, Kaori; Yamada, Kumiko; Tsuchida, Toshie; Otani, Naruhito; Takahashi, Yoshiko; Ishihara, Mika; Takubo, Shingo; Iijima, Kosuke; Ikeuchi, Hiroki; Uchino, Motoi; Kimura, Takeshi; Takesue, Yoshio.
Affiliation
  • Ueda T; Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. Electronic address: taka76@hyo-med.ac.jp.
  • Nakajima K; Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. Electronic address: nakajima@hyo-med.ac.jp.
  • Ichiki K; Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. Electronic address: ichiki@hyo-med.ac.jp.
  • Ishikawa K; Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. Electronic address: i-kaori@hyo-med.ac.jp.
  • Yamada K; Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan; Department of Clinical Technology, Hyogo College of Medicine, Hyogo, Japan. Electronic address: yamakumi@hyo-med.ac.jp.
  • Tsuchida T; Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. Electronic address: tsuchida@huhs.ac.jp.
  • Otani N; Department of Public Health, Hyogo College of Medicine, Nishinomiya, Nishinomiya, Hyogo, Japan. Electronic address: n-otani@hyo-med.ac.jp.
  • Takahashi Y; Department of Pharmacy, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo, Japan. Electronic address: yktabu@hyo-med.ac.jp.
  • Ishihara M; Department of Pharmacy, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo, Japan. Electronic address: ykkura@hyo-med.ac.jp.
  • Takubo S; Department of Pharmacy, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo, Japan. Electronic address: stakubo@hyo-med.ac.jp.
  • Iijima K; Department of Clinical Technology, Hyogo College of Medicine, Hyogo, Japan. Electronic address: ko-iizima@hyo-med.ac.jp.
  • Ikeuchi H; Department of Inflammatory Bowel Disease, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. Electronic address: ikeuci2s@hyo-med.ac.jp.
  • Uchino M; Department of Inflammatory Bowel Disease, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. Electronic address: uchino2s@hyo-med.ac.jp.
  • Kimura T; Department of Pharmacy, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo, Japan. Electronic address: t-kimura@hyo-med.ac.jp.
  • Takesue Y; Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan; Department of Clinical Infectious Diseases, Tokoname City Hospital, Tokoname, Aichi, Japan. Electronic address: takesuey@hyo-med.ac.jp.
J Infect Chemother ; 28(7): 1023-1028, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35477667

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Country of publication: Netherlands